2-Minute heart scan could transform emergency diagnosis of heart failure

NCT ID NCT07685106

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial evaluates a new device called CardioStory that uses fiber-optic sensors to measure heart filling pressure in about two minutes—without needles or catheters. Researchers are enrolling 850 adults who come to the emergency department with recent shortness of breath. The goal is to see if the device can accurately distinguish heart failure from other causes like lung problems, helping doctors make faster, more informed decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CardioStory device (non-invasive cardiac assessment device)
What this could lead to
If successful, this device could help emergency doctors quickly tell whether shortness of breath is due to heart failure or another cause, without invasive procedures.
What could go wrong
The device is still being tested and may not prove accurate enough to replace standard diagnostic methods. Results may vary across different patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSPNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fattouma bourguiba university hospital

    RECRUITING

    Monastir, Monastir Governorate, 5000, Tunisia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Sahloul university hospital

    RECRUITING

    Sousse, 4054, Tunisia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.